Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1150731.RAARw0kwnBkjy2ErN-cXta-Gwi4B2RrCnBF4FznSI6uKM130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150731.RAARw0kwnBkjy2ErN-cXta-Gwi4B2RrCnBF4FznSI6uKM130_provenance.
• NP1150738.RAZiwtnV_EcyeJtnh6V28m8z0jn953CGoDYw3WQjOqWVQ130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150738.RAZiwtnV_EcyeJtnh6V28m8z0jn953CGoDYw3WQjOqWVQ130_provenance.
• NP1150734.RAvjq5m8SnfmeBbgC5c3QCJjMSBCV8Z5P38kR2DEYY51I130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150734.RAvjq5m8SnfmeBbgC5c3QCJjMSBCV8Z5P38kR2DEYY51I130_provenance.
• NP1150737.RAt2zy8OUfs2jehlpzt8fT7Zch9ehHLXtBB-kRpKWBlvc130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150737.RAt2zy8OUfs2jehlpzt8fT7Zch9ehHLXtBB-kRpKWBlvc130_provenance.
• NP1150740.RAjgBUNVcNGVYfBUeW5Xe2k32nOFiKzYnRzibFYJCCzxs130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150740.RAjgBUNVcNGVYfBUeW5Xe2k32nOFiKzYnRzibFYJCCzxs130_provenance.
• NP1150733.RALOvdGIsulsV8eF7-DGoxXY1xckJAaFBUfuL5Vk4v83k130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150733.RALOvdGIsulsV8eF7-DGoxXY1xckJAaFBUfuL5Vk4v83k130_provenance.
• NP1150736.RA_W_uRIwZH5TQxxcCel1Y-dLZbVOomB3AlUr312oDfp8130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150736.RA_W_uRIwZH5TQxxcCel1Y-dLZbVOomB3AlUr312oDfp8130_provenance.
• NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_provenance.